Related Experiment Video
Updated: Jun 24, 2026

07:31
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.0K
Development and validation of a multivariable Prediction Model for Pre-diabetes and Diabetes using Easily Obtainable
Medrxiv : the Preprint Server for Health Sciences
|February 24, 2025
Summary
Easily obtainable clinical data can improve pre-diabetes and diabetes diagnosis beyond hemoglobin A1c testing alone. A new model using vitals, fasting labs, and health factors showed higher accuracy in identifying these conditions.
Area of Science:
- Endocrinology
- Public Health
- Medical Informatics
Background:
- Prevalence of pre-diabetes and diabetes is rising in the US, often alongside other chronic conditions.
- Hemoglobin A1c is a common diagnostic tool but can be inaccurate with co-existing diseases.
- There is a need for improved diagnostic methods for pre-diabetes and diabetes.
Purpose of the Study:
- To evaluate if readily available clinical data can enhance pre-diabetes and diabetes diagnosis compared to hemoglobin A1c alone.
- To develop and validate a predictive model using accessible clinical information.
Main Methods:
- Cross-sectional analysis of 13,800 participants from the US National Health and Nutrition Examination Survey (2005-2016).
- A machine learning model (gradient boosted decision tree) was used to estimate 2-hour glucose levels.
- Comparison of model performance (AUROC, predictive value, net benefit) against hemoglobin A1c and fasting plasma glucose.
Main Results:
- The 20-feature prediction model significantly outperformed hemoglobin A1c and fasting plasma glucose in diagnosing pre-diabetes and diabetes.
- Area-under-the-receiver-operating-curve (AUROC) improved from 0.66/0.71 to 0.77 for pre-diabetes and 0.87/0.88 to 0.91 for diabetes.
- Key features included standard vitals, fasting/non-fasting labs (glucose, insulin, lipids, liver function, kidney function), and the Poverty Ratio.
Conclusions:
- Incorporating easily accessible clinical data into electronic medical records can identify patients with undiagnosed pre-diabetes and diabetes.
- This approach may lead to earlier diagnosis and intervention, potentially preventing severe complications.
- The findings highlight the utility of a multivariable prediction model for improving diabetes screening.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

